Thyroid Peroxidase (TPO) is not classified as a classic tumor marker used for screening or monitoring oncology patients for cancer. Instead, TPO is a specific intracellular enzyme found naturally within the thyroid gland that plays an essential role in synthesizing thyroid hormones. Elevated levels of anti-TPO antibodies serve as a primary clinical biomarker for diagnosing autoimmune thyroid diseases, most notably Hashimoto's thyroiditis and Graves' disease. While chronic inflammation from autoimmune conditions can occasionally overlap with complex clinical evaluations, TPO testing specifically measures immune system activity against the thyroid rather than tracking malignant tumor growth.
1 votes
Marked as accepted